The AllTrials campaign is shining a spotlight on clinical trials that haven’t published results, one per week from now on in the BMJ. Read more about this new series in the BMJ.

The trials we write about will be one of those flagged by the FDAAA Compliance Tracker as overdue reporting results. We’re asking the hundreds of patient groups and thousands of people who are part of the AllTrials campaign to suggest trials they would like to see highlighted so the trials we publicise weekly could be on any treatment or any disease area.

We are publicising unreported clinical trials to get the results reported. We know this works. In February 2018 the team at the EBMDataLab which developed the tracker highlighted one unreported trial on their blog and 7 days later the research team responsible at Columbia University reported the results.

The FDAAA Compliance Tracker is aimed at trying to stop new clinical trials from going overdue. In the meantime, AllTrials is working to get missing results from old trials published – the results we need to make good decisions about today’s and tomorrow’s medicines. If you can help us with that, please consider donating to AllTrials.

Here are the Unreported Clinical Trials of the Week:

18 July 2018: NCT01976936 A randomized trial involving 164 adult stroke patients investigating statin therapy as treatment to aid acute post-stroke recovery. This unreported trial was sponsored by the study PI, Dr. Mitchell S Elkind of Columbia University in collaboration with the National Institute of Neurological Disorders and Stroke.

10 July 2018: NCT02461745 A non-randomized trial involving 200 hepatitis C patients investigating the impact of antiviral medication on treatment of hepatitis C. This trial was sponsored by Kaiser Permanente in California, USA in collaboration with AbbVie.

3 July 2018: NCT01576783 A randomized trial involving 307 preterm babies to investigate the impact of fatty acid supplements on their development. This trial was run by Sara Keim PhD of Nationwide Children’s Hospital in Columbus, Ohio.

26 June 2018: NCT02045901 A multicenter trial with 128 pregnant adolescents investigating a drug for the treatment of pregnancy-induced nausea and vomiting. This trial was sponsored by Duchesnay Inc. in collaboration with Premier Research Group plc.

13 June 2018: NCT00450463 A randomized trial with 53 participants evaluating the effectiveness of vaccine therapy in combination with medication for treatment of prostate cancer. This unreported trial was sponsored by the National Cancer Institute in collaboration with the National Institutes of Health Clinical Center.

5 June 2018: NCT02504580, NCT02762929, NCT02689258 Three randomized trials with 1,170 enrolled participants investigating the role of the drug HTX-011 in treatment of post-operative pain after hernia surgery, bunion removal surgery, and tummy tuck surgery. All three trials were sponsored by Heron Therapeutics.

29 May 2018: NCT02111174 A randomized trial with 30 adults investigating the effects of electrical stimulation therapy for treatment of chemotherapy-induced pain. This trial was sponsored by the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital.

22 May 2018NCT02097641 A randomized trial involving 60 adult participants with respiratory distress syndrome investigating the role of human stem cells in treatment of this syndrome. This unreported trial was sponsored by Dr. Michael Mattay of the University of California, San Francisco in collaboration with National Heart, Lung, and Blood Institute, Massachusetts General Hospital, Stanford University, the University of Pittsburgh, and the University of Minnesota.

15 May 2018: NCT01922258 A trial involving 270 seniors evaluating the effectiveness of an anti-psychotic medication to treat agitation associated with Alzheimer’s. This unreported trial was sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc. in collaboration with H. Lundbeck A/S.

8 May 2018: NCT00515281 A double blind study with around 484 premature infants investigating the effects of inhaled nitric oxide on their brain development. This study was sponsored by the University of Chicago.

2 May 2018: NCT01010126 A non-randomized trial with 252 adults investigating the use of two cancer treatments. It was lead by Dr. Henry Pitot of the Mayo Clinic. This unreported trial was sponsored by the National Cancer Institute and funded under 17 separate NCI grant contracts.

25 April 2018: NCT02076893 A study involving 64 children investigating pain medication in tonsillectomies. The PI for this trial is Dr. Stefan J Friedrichsdorf and it was sponsored by the Children’s Hospitals and Clinics of Minnesota.

17 April 2018: NCT02752646 A randomized trial involving 200 cataract surgery patients to compare the tolerability of different anti-inflammatory eye-drops. This PI for this trial is at the Jules Stein Eye Institute at UCLA and it was sponsored by MDbackline LLC in collaboration with Alcon Research.

11 April 2018: NCT01535937 A randomized trial with 55 cocaine dependent adults to investigate whether ketamine is an effective treatment for cocaine addiction. The study was sponsored by New York State Psychiatric Institute in collaboration with the National Institute on Drug Abuse.

4 April 2018: NCT03115177 A study involving 56 adult patients investigating whether a commonly used antibiotic can prevent better infection after shoulder surgery than the standard treatment, sponsored by Rush University Medical Centre in Chicago.

26 March 2018: NCT0213326 A double blind trial of commonly used pain killers for relief of pain after tooth extraction involving 67 adults. It was run by Tufts University School of Medicine between 2014 and 2016.